Skip to main content
SpringerLink
Log in

Palliative Treatment of Neoplastic Meningitis Protects Against Neurological Deterioration

  • New Drugs and Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Chamberlain MC, Kormanik PA. Neoplastic meningitis: a guide to diagnosis and treatment. CNS Drugs 1998 Jul; 10 (1): 25–41

    Article  Google Scholar 

  2. Zachariah B, Zachariah SB, Varghese R, et al. Carcinomatous meningitis: clinical manifestations and management. Int J Clin Pharmacol Ther 1995; 33 (1): 7–12

    PubMed  CAS  Google Scholar 

  3. Chamberlain M, Dirr L. Involved field radiotherapy and intra-ommaya methotrexate/ara-C in patients with AIDS-related lymphomatous meningitis. J Clin Oncol 1993; 11: 1978–84

    PubMed  CAS  Google Scholar 

  4. Rosen S, Aisner J, Makuch R, et al. Carcinomatous leptomeningitis in small cell lung cancer: a clinicopathologic review of the National Cancer Institute Experience. Am J Med 1982; 61: 45–53

    CAS  Google Scholar 

  5. Lishner M, Perrin R, Feld R, et al. Complications associated with ommaya reservoirs in patients with cancer. Arch Intern Med 1990; 150: 173–8

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Palliative Treatment of Neoplastic Meningitis Protects Against Neurological Deterioration. Drugs Ther. Perspect 13, 5–8 (1999). https://doi.org/10.2165/00042310-199913060-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199913060-00002

Keywords

Search

Navigation